69719-54-6Relevant articles and documents
Synthesis method of dibenzyl sulfide
-
Paragraph 0008-0012; 0028-0030, (2021/02/06)
As an important organic intermediate and a synthesis reagent, an organic sulfur compound also has unique pharmacological effects of resisting tumors, inflammation, bacteria and oxidation, preventing aging, preventing and treating cardiovascular diseases and the like. The patent develops a method for synthesizing dibenzyl sulfide without metal catalysis. In an acetonitrile solution, benzyl trifluoromethanesulfonic acid quaternary ammonium salt and sodium sulfide nonahydrate are used to synthesize dibenzyl sulfide in a wide substrate range with good to excellent yield through breakage of a carbon-nitrogen bond and generation of a carbon-sulfur bond. The method has the advantages of mild reaction conditions, simple operation, no metal, high yield, wide substrate applicability and the like.
Indium-catalyzed direct preparation of dibenzyl sulfides from benzyl alcohols and elemental sulfur with a hydrosilane and its application to the preparation of dibenzyl selenide
Miyazaki, Takahiro,Katayama, Masahiro,Yoshimoto, Shunsuke,Ogiwara, Yohei,Sakai, Norio
supporting information, p. 676 - 679 (2016/01/26)
We describe how a reducing system composed of InI3 and a hydrosilane efficiently and directly introduce elemental sulfur into the structure of dibenzyl sulfides via a nucleophilic substitution of benzyl alcohols. Also, we describe the application of this reducing system in the direct preparation of a dibenzyl selenide derivative with selenium.
Azaindole derivatives useful as cholesterol biosynthesis inhibitors
-
, (2008/06/13)
Compounds of the formula I: STR1 wherein X is the residue of an unsubstituted 6-membered aromatic ring having 3 carbon atoms and one nitrogen atom; R1 is C1-6 primary alkyl (free of asymmetric carbon atoms), or isopropyl; R2 is substituted or unsubstituted phenyl, primary or secondary C1-6 alkyl (free of asymmetric carbons), C3-6 cycloalkyl or phenalkyl as defined in the Specification STR2 in which R8 is hydrogen, R9 or M, wherein R9 is a physiologically acceptable and hydrolyzable ester group, and M is a pharmaceutically acceptable cation; are obtained by multi-step processes and are useful as cholesterol biosynthesis inhibitors. 3